MDMA-Assisted Psychotherapy Is Not Ecstasy
Sarah Rosenzweig (she/her) was born and raised in Oakville, Ontario. In addition to her major in Professional Communication, Sarah is double-minoring in Public Relations and Sociology. She hopes to pursue a master’s degree in communications or pursue Law School within the next five years. She is most interested in working with public relations and potentially PR Litigation.
This research project examines peer-reviewed literature surrounding post-traumatic stress disorder and psychedelics. Specifically, this research aimed to determine whether Psilocybin or MDMA was more effective at relieving symptoms of PTSD when paired with psychotherapy. After extensively examining clinical studies and understanding the pharmacological makeup of both substances through extensive research, it was found that MDMA is more effective at relieving symptoms of PTSD in psychedelic-assisted psychotherapy, whereas Psilocybin is more effective at treating treatment-resistant depression(s) when paired with psychotherapy. A qualitative approach to gathering data was utilized and extensive document analysis was implemented.
Psychedelic-Assisted Psychotherapy; Psychedelics; Mental Health; PTSD